Paliperidone Extended Release in Schizophrenia Participants With Duration of Illness Less Than 10 Years
NCT01362439
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
133
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
Paliperidone ER
Sponsor
Janssen-Cilag S.p.A.